Clouth, Johannes; Liepa, Astra M.; Moeser, Guido; … - In: Health Economics Review 8 (2018) 18, pp. 1-10
-line therapy following sorafenib in Germany and the healthcare costs accrued by patients meeting eligibility criteria. Methods …: Patients with an HCC diagnosis and one or more sorafenib prescription were identified from samples of > 3 million insured … and Robert Koch Institute. Resource use and cost data were collected for a subset of patients with follow-up data post-sorafenib …